372 Letters in Organic Chemistry, 2014, Vol. 11, No. 5
Grün et al.
3.7. Preparation of Fenidronate Disodium Salt (4) from
Ethyl Benzoate
aqueous sodium hydroxide to the mixture. Then 127 ml of
methanol was added, the mixture stirred for 45 min and the
precipitate was removed by filtration. The crude product was
dissolved in 10 ml of hot water and 50 ml of methanol was
added, then the precipitate was filtered off and dried to give
13.3 g of fenidronate disodium salt (4) in a purity of ca. 67%
(on the basis of 31P NMR). The precipitation was repeated
twice by adding 50 ml of methanol to the 10 ml water
solution of the crude product. Then the solid product was
suspended in the 50 ml mixture of methanol-water 94:6 and
the mixture was digested by stirring at 65 °C for 30 min,
then the solid product was filtered off. This procedure was
repeated twice to afford 3.6 g (46%) of fenidronate disodium
salt (4) in a purity of 100%. 31P NMR (D2O) ꢀ: 16.0, ꢀ[15]
16.39, 13C NMR (D2O) ꢀ: 136.9 (t, J=2.3, C1), 128.1 (t,
J~2.1, C3*), 127.4 (t, J~2.1, C4), 126.0 (t, J = 4.4, C2*), 76.5
(t, J = 140.9, P-C-P), ꢀ [24] 135.7, 128.1, 127.7, 125.8,
75.7 (t, J = 145.1), *may be reversed.
3.6 ml (0.025 mol) of ethyl benzoate was dissolved in
10.5 ml of methanesulfonic acid on stirring. 4.8 ml (0.055
mol) of phosphorus trichloride was added dropwise and the
mixture was stirred at 75 °C for 24 h. Further processment
including hydrolysis, pH adjustment and precipitation with
MeOH was performed as described above to give 3.0 g
(36%) of fenidronate disodium salt (4) in a purity of 94%.
31P NMR (D2O) ꢀ: 16.6.
CONFLICT OF INTEREST
The authors confirm that this article content has no
conflict of interest.
ACKNOWLEDGEMENTS
The research was supported by Gedeon Richter Plc and
by Hungarian Scientific and Research Fund (OTKA
K83118).
3.4. Preparation of Fenidronate Disodium Salt (4)
Applying Phosphorus Trichloride in a Two Step Reaction
(Table 2/Entry 1)
3.1 g (0.025 mol) of benzoic acid was dissolved in 10.5
ml of methanesulfonic acid on stirring. 2.3 ml (0.026 mol) of
phosphorus trichloride was added dropwise and the mixture
was stirred at 26 °C for 6 h. Then, 4.8 ml (0.055 mol) of
phosphorus trichloride was added dropwise and the mixture
was stirred at 75 °C for 18 h. Further processing including
hydrolysis, pH adjustment and precipitation with MeOH was
performed as described above to afford 14,1 g of crude
product. After the two precipitations with MeOH and three
digestions with MeOH/water 94:6 carried out similarly as
above, 3.4 g (43%) of fenidronate disodium salt (4) was
obtained in a purity of 98%. 31P NMR (D2O) ꢀ: 16.7.
REFERENCES
[1]
[2]
[3]
[4]
Russell, R. G. G. Bisphosphonates: The first 40 years. Bone, 2011,
49, 2-19.
Breuer, E. In Analogue-based drug discovery; Fischer, J.; Ganelli,
C. R., Eds.; Wiley-VCH: Weinheim, 2006.
Russell, R. G. G. Bisphosphonates: Mode of action and
pharmacology. Pediatrics, 2007, 119, S150-S162.
Widler, L.; Jaeggi, K. A.; Glatt, M.; Müller, K.; Bahmann, R.;
Bisping, M.; Born, A.-R.; Cortesi, R.; Guiglia, G.; Jeker, H.; Klein,
R.; Ramseier, U.; Schmid, J.; Schreiber, G.; Seltenmeyer, Y.;
Green, J. R. Highly potent geminal bisphosphonates. From
pamidronate disodium (Aredia) to zoledronic acid (Zometa). J.
Med. Chem., 2002, 45, 3721-3738.
[5]
[6]
Hudson H. R., Wardle N. J., Blight S. W. A., Greiner I., Grün A.,
Keglevich G. N-Heterocyclic Dronic acids; applications and
synthesis. Mini-Rev. Med. Chem., 2012, 12, 313-325.
Rogers, M. J.; Frith, J. C.; Luckman, S. P.; Coxon, E. P.; Benford,
H. L.; Mönkkönen, J.; Auriola, S.; Chilton, K. M.; Russell, R. G.
G. Molecular mechanisms of action of bisphosphonates. Bone,
1999, 24, (Suppl.) 73S-79S.
3.5. Preparation of Fenidronate Disodium Salt (4) with
Thionyl Chloride and Phosphorus Trichloride in a Two
Step Reaction (Table 2/Entry 3)
[7]
Russell, R. G. G.; Croucher, P. I.; Rogers, M. J. Bisphosphonates:
Pharmacology, mechanisms of action and clinical uses.
Osteoporosis Int., 1999, 9, S66-S80.
3.1 g (0.025 mol) of benzoic acid was dissolved in 10.5
ml of methanesulfonic acid on stirring. 1.9 ml (0.026 mol) of
thionyl chloride was added dropwise and the mixture was
stirred at 26 °C for 6 h. Further processing including the
second step with phosphorus trichloride, hydrolysis, pH
adjustment and precipitation with MeOH was performed as
described above to afford 2.1 g (26%) of fenidronate
disodium salt (4) in a purity of 97%. 31P NMR (D2O) ꢀ: 16.6.
[8]
[9]
Russell, R. G. G.; Rogers, M. J. Bisphosphonates: From the
laboratory to the clinic and back again. Bone, 1999, 25, 97-106.
Roelofs, A. J.; Thompson, K.; Gordon, S.; Rogers, M. J. Molecular
mechanisms of action of bisphosphonates: Current status. Clin.
Cancer. Res., 2006, 12, 6222S-6230S.
Keglevich, G.; Greiner, I. The meeting of two disciplines:
organophosphorus and green chemistry. Curr. Green Chem., 2014,
1, 2-16.
Alovitdinov, A. B.; Khamrakulov, G. B.; Khalmukhamedova, M.
V.; Agzamov, T. A. On mechanism of the formation of 1-hydroxyl-
containing monophosphonic and diphosphonic acids. Russ. J. Gen.
Chem., 1996, 66, 769-771.
[10]
[11]
3.6. Preparation of Fenidronate Disodium Salt (4) from
Benzoyl Chloride
[12]
[13]
[14]
Lecouvey, M.; Mallard, I.; Bailly, T.; Burgada, R.; Leroux, Y. A
mild and efficient one-pot synthesis of 1-hydroxymethylene-1,1-
bisphosphonic acids. Preparation of new tripod ligands.
Tetrahedron Lett., 2001, 42, 8475-8478.
2.9 ml (0.025 mol) of benzoyl chloride was dissolved in
10.5 ml of methanesulfonic acid on stirring. 4.8 ml (0.055
mol) of phosphorus trichloride was added dropwise and the
mixture was stirred at 75 °C for 24 h. Further processing
including hydrolysis, pH adjustment and precipitation with
MeOH was performed as described above to provide 2.7 g
(35%) of fenidronate disodium salt (4) in a purity of 100%.
31P NMR (D2O) ꢀ: 16.4.
Guenin, E.; Degache, E.; Liquier, J.; Lecouvey, M. Synthesis of 1-
hydroxymethylene-1,1-bis(phosphonic
acids)
from
acid
anhydrides: Preparation of a new cyclic 1-acyloxymethylene-1,1-
bis(phosphonic acid). Eur. J. Org. Chem., 2004, 14, 2983-2987.
Lecouvey, M.; Leroux, Y.; Kraemer, M.; Crepin, M.; Manouni, D.
E.; Louriki, M. Bisphosphonate derivatives, their preparations and
uses. U.S. Patent 20,030,036,537, February 20, 2003.